A carregar...
ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia–reperfusion injury, in order to improve clinical outcomes in IHD patients. In this regard, alt...
Na minha lista:
| Publicado no: | Cardiovasc Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4242141/ https://ncbi.nlm.nih.gov/pubmed/25344369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvu225 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|